The Asia Pacific Diabetic Footwear Market would witness market growth of 8.8% CAGR during the forecast period (2023-2030). In the year 2021, the Asia Pacific market's volume surged to 40,511.5 thousand Units, showcasing a growth of 8.6% (2019-2022).
Diabetic shoes are typically designed with minimal seams or with seams placed in such a way as to minimize friction and irritation against the skin. This is crucial for preventing the formation of blisters and sores, which can be exacerbated in individuals with reduced sensation. Diabetic footwear often features wider toe boxes to accommodate any deformities or swelling that may occur in individuals with diabetes. This helps to prevent the toes from rubbing against the shoe, reducing the risk of friction-related injuries.
Diabetic footwear often utilizes materials that promote breathability and moisture control, preventing the accumulation of moisture that could lead to fungal infections. This holds particular significance for individuals diagnosed with diabetes, given their heightened vulnerability to complications pertaining to the epidermis. Specialized designs aim to minimize shear and friction, reducing the risk of blisters and calluses. This preventive approach aligns with the overarching goal of diabetic footwear to protect the foot from potential harm. The market is dynamic, witnessing several trends that shape product development and consumer preferences.
As per the data from the Government of Australia, the National Diabetes Services Scheme (NDSS) and Australasian Paediatric Endocrine Group (APEG) state-based registers recorded that in 2021, approximately 1 in 20 Australians (approximately 1.3 million) were living with diabetes (prevalence). With nearly one in every five Australians aged 80–84 having diabetes in 2021, the incidence rate was nearly thirty times that of those aged below 40 (0.7%). Upon accounting for age, the prevalence of diabetes in males was 1.3 times that of females. Thus, the increasing prevalence of diabetes in the Asia Pacific region will positively impact the regional market.
The China market dominated the Asia Pacific Diabetic Footwear Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $929.6 Million by 2030. The Japan market is registering a CAGR of 8% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 9.4% during (2023 - 2030).
Based on End User, the market is segmented into Women and Men. Based on Type, the market is segmented into Shoes, Sandals and Slippers. Based on Distribution Channel, the market is segmented into Specialty Stores, Online Platform, Footwear Stores and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include New Balance Athletics, Inc., SKECHERS USA, Inc., Orthofeet, Inc. (Webster Equity Partners), DJO Global (Enovis Corporation), Drew Shoe Corporation, Wolverine World Wide, Inc., Podartis Srl, I-Runner (Healer Health LLC), Pilgrim Shoes and Aetrx Worldwide, Inc.
Diabetic shoes are typically designed with minimal seams or with seams placed in such a way as to minimize friction and irritation against the skin. This is crucial for preventing the formation of blisters and sores, which can be exacerbated in individuals with reduced sensation. Diabetic footwear often features wider toe boxes to accommodate any deformities or swelling that may occur in individuals with diabetes. This helps to prevent the toes from rubbing against the shoe, reducing the risk of friction-related injuries.
Diabetic footwear often utilizes materials that promote breathability and moisture control, preventing the accumulation of moisture that could lead to fungal infections. This holds particular significance for individuals diagnosed with diabetes, given their heightened vulnerability to complications pertaining to the epidermis. Specialized designs aim to minimize shear and friction, reducing the risk of blisters and calluses. This preventive approach aligns with the overarching goal of diabetic footwear to protect the foot from potential harm. The market is dynamic, witnessing several trends that shape product development and consumer preferences.
As per the data from the Government of Australia, the National Diabetes Services Scheme (NDSS) and Australasian Paediatric Endocrine Group (APEG) state-based registers recorded that in 2021, approximately 1 in 20 Australians (approximately 1.3 million) were living with diabetes (prevalence). With nearly one in every five Australians aged 80–84 having diabetes in 2021, the incidence rate was nearly thirty times that of those aged below 40 (0.7%). Upon accounting for age, the prevalence of diabetes in males was 1.3 times that of females. Thus, the increasing prevalence of diabetes in the Asia Pacific region will positively impact the regional market.
The China market dominated the Asia Pacific Diabetic Footwear Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $929.6 Million by 2030. The Japan market is registering a CAGR of 8% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 9.4% during (2023 - 2030).
Based on End User, the market is segmented into Women and Men. Based on Type, the market is segmented into Shoes, Sandals and Slippers. Based on Distribution Channel, the market is segmented into Specialty Stores, Online Platform, Footwear Stores and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include New Balance Athletics, Inc., SKECHERS USA, Inc., Orthofeet, Inc. (Webster Equity Partners), DJO Global (Enovis Corporation), Drew Shoe Corporation, Wolverine World Wide, Inc., Podartis Srl, I-Runner (Healer Health LLC), Pilgrim Shoes and Aetrx Worldwide, Inc.
Scope of the Study
Market Segments Covered in the Report:
By End User (Volume, Thousand Units, USD Billion/Million, 2019-2030)- Women
- Men
- Shoes
- Sandals
- Slippers
- Specialty Stores
- Online Platform
- Footwear Stores
- Others
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- New Balance Athletics, Inc.
- SKECHERS USA, Inc.
- Orthofeet, Inc. (Webster Equity Partners)
- DJO Global (Enovis Corporation)
- Drew Shoe Corporation
- Wolverine World Wide, Inc.
- Podartis Srl
- I-Runner (Healer Health LLC)
- Pilgrim Shoes
- Aetrx Worldwide, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 5. Asia Pacific Diabetic Footwear Market by End User
Chapter 6. Asia Pacific Diabetic Footwear Market by Type
Chapter 7. Asia Pacific Diabetic Footwear Market by Distribution Channel
Chapter 8. Asia Pacific Diabetic Footwear Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- New Balance Athletics, Inc.
- SKECHERS USA, Inc.
- Orthofeet, Inc. (Webster Equity Partners)
- DJO Global (Enovis Corporation)
- Drew Shoe Corporation
- Wolverine World Wide, Inc.
- Podartis Srl
- I-Runner (Healer Health LLC)
- Pilgrim Shoes
- Aetrx Worldwide, Inc.
Methodology
LOADING...
